LSTA
LSTA
NASDAQ · Biotechnology

Lisata Therapeutics Inc

$1.09
-0.04 (-3.54%)
As of Aug 15, 2:25 AM ET ·
Financial Highlights (FY 2026)
Revenue
188.0K
Net Income
-18,309,461
Gross Margin
9.6%
Profit Margin
-9,756.5%
Rev Growth
-78.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 9.6% 9.6% 60.2% 60.2%
Operating Margin -10,711.2% -9,640.1% -3.8% -3.7%
Profit Margin -9,756.5% -9,268.7% -3.8% -3.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 188.0K 888.3K 5.21M 4.72M
Gross Profit 18.0K 84.9K 3.14M 2.84M
Operating Income -20,132,305 -85,628,896 -199,396 -176,250
Net Income -18,309,461 -77,875,779 -195,079 -179,711
Gross Margin 9.6% 9.6% 60.2% 60.2%
Operating Margin -10,711.2% -9,640.1% -3.8% -3.7%
Profit Margin -9,756.5% -9,268.7% -3.8% -3.8%
Rev Growth -78.8% -78.8% -0.3% +24.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 21.25M 18.39M
Total Equity 13.67M 13.06M
D/E Ratio 1.55 1.41
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -19,939,697 -89,521,323 -244,954 -200,080
Free Cash Flow -167,798 -115,643